Medicines

Our medicines are approved in individual countries for specific uses and the information we provide for patients is governed by local regulations.

You should visit your local AstraZeneca site to find out more about our medicines in your country. In some countries we are not allowed to provide very much, or sometimes any, information on our prescription medicines so you should seek alternative trustworthy sources. Always ask a healthcare professional for advice about medicines.


Reporting of side effects

The safety of our patients is very important to us.
 

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet.
 

By reporting any side effects that you may experience, you are helping to provide more information on the safety of our medicines. Report a possible side-effect to AstraZeneca by clicking here. If you are based in the UK, you can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard.

 

Cardiovascular, Renal and Metabolic Diseases

Please note that the products mentioned may not be available in all countries. Additionally, currently approved indications (uses) and presentations may differ between countries. Country specific information is available from your local AstraZeneca company.

  • Atacand, Atacand HCT, Atacand Plus candesartan cilexetil
  • Brilinta/Brilique ticagrelor
  • Bydureon exenatide
  • Byetta exenatide injection
  • Crestor rosuvastatin
  • Farxiga/Forxiga dapagliflozin
  • Kombiglyze XR saxagliptin and metformin XR
  • Komboglyze saxagliptin and metformin HCl
  • Onglyza saxagliptin
  • Plendil, Modip, Splendil, Munobal, Flodil felodipine
  • Seloken ZOK, Toprol-XL, Betaloc ZOK metoprolol succinate
  • Symlin pramlintide acetate
  • Tenormin, Tenormine, Prenormine, Atenol atenolol
  • Zestril lisinopril dihydrate
  • XIGDUO dapagliflozin and metformin HCI
  • XIGDUO XR dapagliflozin and metformin HCI extended-release
  • Qtern dapagliflozin and saxagliptin

Oncology

Please note that the products mentioned may not be available in all countries. Additionally, currently approved indications (uses) and presentations may differ between countries. Country specific information is available from your local AstraZeneca company.

  • Arimidex anastrozole
  • Calquence acalabrutinib
  • Casodex, Cosudex bicalutamide
  • Faslodex fulvestrant
  • Imfinzi durvalumab
  • Iressa gefitinib
  • Lynparza olaparib
  • Tagrisso osimertinib
  • Zoladex goserelin acetate implant

Infection and Vaccines

Please note that the products mentioned may not be available in all countries. Additionally, currently approved indications (uses) and presentations may differ between countries. Country specific information is available from your local AstraZeneca company.

  • Synagis palivizumab
  • Fluenz Tetra/FluMist Quadrivalent influenza vaccine live, intra-nasal

Neuroscience

Please note that the products mentioned may not be available in all countries. Additionally, currently approved indications (uses) and presentations may differ between countries. Country specific information is available from your local AstraZeneca company.

  • Diprivan propofol
  • EMLA EMLA
  • Movantik/Moventig naloxegol
  • Naropin ropivacaine
  • Seroquel IR quetiapine fumarate
  • Seroquel XR quetiapine fumarate
  • Xylocaine lidocaine
  • Zomig, Zomig Rapimelt, Zomig Nasal Spray, AscoTop, Zomigon zolmitriptan

Respiratory

Please note that the products mentioned may not be available in all countries. Additionally, currently approved indications (uses) and presentations may differ between countries. Country specific information is available from your local AstraZeneca company.

  • Accolate, Accoleit, Vanticon zafirlukast
  • Bricanyl Respules terbutaline
  • Bricanyl Turbuhaler terbutaline in a dry powder inhaler
  • Daliresp/Daxas roflumilast
  • Duaklir Genuair aclidinium/formoterol
  • Eklira Genuair/Tudorza/Bretaris aclidinium, a LAMA
  • Fasenra benralizumab
  • Oxis Turbuhaler Oxis Turbuhaler
  • Pulmicort Turbuhaler budesonide
  • Pulmicort Respules budesonide inhalation suspension
  • Rhinocort budesonide
  • Symbicort pMDI budesonide/formoterol
  • Symbicort Turbuhaler budesonide/formoterol
  • Bevespi Aerosphere glycopyrronium/formoterol fumarate

Gastrointestinal

Please note that the products mentioned may not be available in all countries. Additionally, currently approved indications (uses) and presentations may differ between countries. Country specific information is available from your local AstraZeneca company.

  • Vimovo naproxen and esomeprazole magnesium
  • Losec, Gastroloc, Mopral, Omepral, Prilosec omeprazole
  • Nexium esomeprazole


Early access to AstraZeneca investigational medicinal products

We recognise that there are circumstances where patients with serious or life-threatening diseases have exhausted all available therapeutic options and may not be eligible to enrol in one of our clinical trials. In such circumstances individual patients may be eligible for early access to an AstraZeneca investigational medicinal product.